These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1038 related items for PubMed ID: 16313260

  • 1. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G, Heiss S, Gastl G, Tzankov A, Stauder R.
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [Abstract] [Full Text] [Related]

  • 2. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG, Hellström-Lindberg E, Kanter-Lewensohn L, Lerner R, Palmblad J.
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [Abstract] [Full Text] [Related]

  • 3. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI, Bolaraki PE, Voulgarelis M.
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [Abstract] [Full Text] [Related]

  • 4. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia.
    Keith T, Araki Y, Ohyagi M, Hasegawa M, Yamamoto K, Kurata M, Nakagawa Y, Suzuki K, Kitagawa M.
    Br J Haematol; 2007 May; 137(3):206-15. PubMed ID: 17408459
    [Abstract] [Full Text] [Related]

  • 5. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
    Qi H, Xiao L, Lingyun W, Ying T, Yi-Zhi L, Shao-Xu Y, Quan P.
    Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
    [Abstract] [Full Text] [Related]

  • 6. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
    Wu LY, Li X, Chang CK, Ying SX, Pu Q.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
    [Abstract] [Full Text] [Related]

  • 7. Increased angiogenesis in the bone marrow of HIV-positive patients with myelodysplasia.
    Patsouris E, Korkolopoulou P, Androulaki A, Douzinas E, Kosmopoulou O, Kordossis T.
    Pathology; 2003 Aug; 35(4):330-5. PubMed ID: 12959769
    [Abstract] [Full Text] [Related]

  • 8. Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows.
    Mundle SD, Mativi BY, Bagai K, Feldman G, Cheema P, Gautam U, Reza S, Cartlidge JD, Venugopal P, Shetty V, Gregory SA, Robin E, Rifkin S, Shah R, Raza A.
    Int J Hematol; 1999 Aug; 70(2):83-90. PubMed ID: 10497846
    [Abstract] [Full Text] [Related]

  • 9. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J, Shao ZH, Liu H, Bai J, Cao YR, He GS, Tu MF, Wang XL, Hao YS, Yang TY, Yang CL.
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [Abstract] [Full Text] [Related]

  • 10. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.
    Cilloni D, Gottardi E, Messa F, Fava M, Scaravaglio P, Bertini M, Girotto M, Marinone C, Ferrero D, Gallamini A, Levis A, Saglio G, Piedmont Study Group on Myleodysplastic Syndromes.
    J Clin Oncol; 2003 May 15; 21(10):1988-95. PubMed ID: 12743153
    [Abstract] [Full Text] [Related]

  • 11. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
    Gianelli U, Fracchiolla NS, Cortelezzi A, Pellegrini C, Savi F, Moro A, Grimoldi MG, Deliliers GL, Coggi G, Bosari S.
    Ann Hematol; 2007 Mar 15; 86(3):185-9. PubMed ID: 17124585
    [Abstract] [Full Text] [Related]

  • 12. [[The role of TNF-alpha in myelodysplastic syndrome: immunoserologic and immunohistochemical studies] ].
    Molnár L, Berki T, Hussain A, Németh P, Losonczy H.
    Orv Hetil; 2000 Aug 13; 141(33):1807-11. PubMed ID: 10979309
    [Abstract] [Full Text] [Related]

  • 13. [Prognostic potential of morphological and cytogenetic indices in patients with myelodysplastic syndrome].
    Gritsaev SV, Martynkevich IS, Abdulkadyrov KM, Tiranova SA, Kakaĭ MP, Martynenko LS, Dziavgo LA.
    Ter Arkh; 2005 Aug 13; 77(7):22-7. PubMed ID: 16116904
    [Abstract] [Full Text] [Related]

  • 14. Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia.
    Kuninaka N, Kurata M, Yamamoto K, Suzuki S, Umeda S, Kirimura S, Arai A, Nakagawa Y, Suzuki K, Kitagawa M.
    Exp Mol Pathol; 2010 Apr 13; 88(2):293-8. PubMed ID: 20132814
    [Abstract] [Full Text] [Related]

  • 15. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
    Tsopra OA, Ziros PG, Lagadinou ED, Symeonidis A, Kouraklis-Symeonidis A, Thanopoulou E, Angelopoulou MK, Vassilakopoulos TP, Pangalis GA, Zoumbos NC.
    Acta Haematol; 2009 Apr 13; 121(4):187-95. PubMed ID: 19468203
    [Abstract] [Full Text] [Related]

  • 16. Angiogenesis in myelodysplastic syndromes.
    Pruneri G, Bertolini F, Soligo D, Carboni N, Cortelezzi A, Ferrucci PF, Buffa R, Lambertenghi-Deliliers G, Pezzella F.
    Br J Cancer; 1999 Dec 13; 81(8):1398-401. PubMed ID: 10604739
    [Abstract] [Full Text] [Related]

  • 17. Effect of cA2 anti-tumor necrosis factor-alpha antibody therapy on hematopoiesis of patients with myelodysplastic syndromes.
    Boula A, Voulgarelis M, Giannouli S, Katrinakis G, Psyllaki M, Pontikoglou C, Markidou F, Eliopoulos GD, Papadaki HA.
    Clin Cancer Res; 2006 May 15; 12(10):3099-108. PubMed ID: 16707608
    [Abstract] [Full Text] [Related]

  • 18. Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.
    Travaglino E, Benatti C, Malcovati L, Della Porta MG, Gallì A, Bonetti E, Rosti V, Cazzola M, Invernizzi R.
    Eur J Haematol; 2008 Mar 15; 80(3):216-26. PubMed ID: 18081721
    [Abstract] [Full Text] [Related]

  • 19. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies.
    Orazi A, Cattoretti G, Heerema NA, Sozzi G, John K, Neiman RS.
    Mod Pathol; 1993 Sep 15; 6(5):521-5. PubMed ID: 8248107
    [Abstract] [Full Text] [Related]

  • 20. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A.
    Pathobiology; 2007 Sep 15; 74(2):97-114. PubMed ID: 17587881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.